T2S Group IPO: Driving Recurring Revenue Growth and Expanding Across Africa

T2S Group Holding is debuting on the Casablanca Stock Exchange with a mixed capital‑raising of up to MAD 1.1 billion. CEO Abderraouf Sordo explains that more than 45 % of the company’s turnover already comes from recurring services—consumables, software subscriptions and its own radiopharmaceutical lab. The IPO will fund a second cyclotron in Fès, targeted acquisitions, and a fast‑track African growth plan that has already delivered a 72 % revenue jump in one year. The Moroccan health sector is undergoing a major transformation, driven by near‑universal health insurance and a push for high‑tech hospitals. T2S positions itself as an integrated MedTech provider that can profit from this shift while delivering stable, repeatable cash flow to investors.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.